(Reuters Health) – People who have a lot of trouble hearing may be almost twice as likely to experience an accidental injury as individuals with excellent or good hearing, a U.S. study suggests. Source: Reuters Medical News
(Reuters Health) – Pregnant women who drink lots of coffee and other caffeinated beverages may be more likely to have kids who are overweight than mothers who limit caffeine during pregnancy, a Norwegian study suggests. Source: Reuters Medical News
(Reuters Health) – Elderly people who are prescribed opioids may be at higher risk for injuries from falls, some of which may be fatal, a Canadian analysis of trauma cases suggests. Source: Reuters Medical News
LOS ANGELES (Reuters) – The largest U.S. manager of prescription benefits is telling drugmakers that the current pricing model is broken, and taking aim at Amgen Inc, Eli Lilly and Co and other makers of new migraine medicines to try and fix it. Source: Reuters Medical News
(Reuters) – The U.S. Food and Drug Administration on Tuesday said it launched a crackdown to curb the sale to minors of e-cigarettes and other tobacco products developed by Juul Labs Inc. Source: Reuters Medical News
GENEVA (Reuters) – Malaria is spreading rapidly in crisis-hit Venezuela, with more than an estimated 406,000 cases in 2017, up roughly 69 percent from a year before, the largest increase worldwide, the World Health Organization (WHO) said on Tuesday. Source: Reuters Medical News
LONDON (Reuters) – The concept of combining two immunotherapy drugs to fight lung cancer – not so long ago one of the hottest ideas in cancer research – has suffered a fresh blow from the failure of an AstraZeneca clinical study. Source: Reuters Medical News
BRUSSELS (Reuters) – Ireland gained EU approval on Tuesday for a tax on sugary drinks after regulators said the levy would help the country tackle health and obesity issues. Source: Reuters Medical News
(Reuters Health) – Women who are heavy drinkers are at increased risk of pre-menstrual syndrome (PMS), new research shows. Source: Reuters Medical News
(Reuters) – An arthritis drug developed by Eli Lilly & Co and Incyte Corp should not be approved at a 4-milligram dose, advisers to the U.S. FDA voted on Monday, in a setback to the drugmakers that were counting on the treatment as a future blockbuster. Source: Reuters Medical News